# EU Expert Panel Recommends Lilly’s Foundayo Weight-Loss Pill

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/33429
Published: 2026-10-16T18:56:10.000Z
Updated: 2026-10-16T18:56:10.000Z
Section: Business

> The oral medicine contains orforglipron and has moved closer to possible approval in the European Union.

An expert panel advising the European Union’s drug regulator recommended marketing authorization for Eli Lilly and Company’s Foundayo, moving the company’s oral weight-loss medicine closer to possible approval in Europe.

Foundayo, which contains orforglipron, is a pill. The endorsement advances Lilly’s position in a market where rival Novo has the first-mover advantage.